Taizhou Huaxin Pharmaceutical Investment Co., Ltd. has a unified social credit code/registration number of 91321291782712917y, and the enterprise is in the state of opening.
The business scope of Taizhou Huaxin Pharmaceutical Investment Co., Ltd. is: foreign investment; Pre-land development and consolidation; Infrastructure construction; Medical technology development services; Medical exhibition service; Technical research and development of vaccines, biological drugs, chemicals and medical devices (excluding the production and sales of drugs and medical devices); Rental of houses, machinery and equipment; Economic information consulting service; Property management; Operation management of pharmaceutical R&D platform, real estate development. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu province, the total registered capital of companies with similar business scope is 32,748.96 million yuan, and the main capital is concentrated in 447 enterprises with a scale of more than 50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Taizhou Huaxin Pharmaceutical Investment Co., Ltd. invested in 12 Company 0 Branch.
View more information and information of Taizhou Huaxin Pharmaceutical Investment Co., Ltd. through Baidu Enterprise Credit.